Timothy P Lynch insider trades: AEON Biopharma (AEON) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
and 2 more companies
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | AEON | ↑ Buy | 1,150,000 | $0.21 | $243K | Direct | Aug 21, 2026 (2d) |
| Mar 17, 2017 | VIVE | ↑ Buy | 1,250,000 | $4.00 | $5.0M | See Notes | Mar 21, 2017 (4d) |
| Jun 17, 2016 | VIVE | ↑ Buy | 300,000 | $5.00 | $1.5M | See | Jun 21, 2016 (4d) |
| Nov 17, 2009 | NABI | ↓ Sell | 3,846 | $5.20 | $20K | Direct | Nov 18, 2009 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Timothy P Lynch's insider trades
Timothy P Lynch is an insider at AEON Biopharma (AEON). Since Nov 17, 2009, Timothy has reported 3 open-market purchases worth $6.7M and 1 sale worth $20K on SEC Form 4. In the last 12 months: 1 buy ($243K).
Their filings also include grants and awards (19 filings), conversions (3 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AEON insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.